Reactive Arthritis: Modern Aspects of Diagnosis and Treatment
https://doi.org/10.37489/0235-2990-2020-65-7-8-63-70
Abstract
Currently, the problem of reactive arthritis (ReA) retains its importance due to the fairly high prevalence of the disease, primarily in Russia. Analysis of epidemiological data allows us to put forward a number of possible reasons explaining the different frequency of ReA in certain regions of the Russian Federation and in other countries. The lecture describes the clinical picture of the disease, as well as analyzes the significance of various laboratory techniques aimed at identifying the causative agent of ReA. The Russian diagnostic criteria for ReA are presented. The main approaches to the therapy of ReA are outlined with an emphasis on the use of antimicrobial drugs. The effectiveness and safety of drug immunocorrection (inducers of interferon, polyoxidonium, immunofan, etc.) in the treatment of urogenital chlamydia in patients with ReA have not been confirmed by data from randomized controlled trials.
About the Authors
B. S. BelovRussian Federation
Moscow
R. M. Balabanova
Russian Federation
Moscow
References
1. Ford D.K. Natural history of arthritis folloving venereal urethritis. Ann Rheum Dis 1953; 12 (3): 177–197.
2. Csonka G.W. Significance of sacro-iliitis in Reiter's disease. Br J Vener Dis 1959; 35: 77-80.
3. Ahvonen P., Sievers K., Aho K. Arthritis associated with Yersinia enterocolitica infection. Acta Rheumatol Scand1969; 5: 232–253.
4. Panush R.S., Wallace D.J., Dorff R.E., Engleman E.P. Retraction of the suggestion to use the term «Reiter's syndrome» sixty-five years later: the legacy of Reiter, a war criminal, should not be eponymic honor but rather condemnation. Arthritis Rheum 2007; 56 (2): 693–694.
5. Hannu T. Reactive arthritis. Best Pract Res Clin Rheumatol 2011; 25 (3): 347–357. doi: 10.1016/j.berh.2011.01.018
6. Inman R.D. Reactive arthritis. In: M.L. Hochberg, A.J. Silman, J.S. Smolen, M.E. Weinblatt, M.H. Weisman, editots. Rheumatology. 6th ed. Philadelphia: Mosby; 2015; 928-940.
7. Zeidler H., Hudson A.P. New insights into Chlamydia and arthritis. Promise of a cure? Ann Rheum Dis 2014; 73: 637–644. doi: 10.1136/annrheumdis-2013-204110
8. Agababova E.R., Bunchuk N.V., Shubin S.V. i dr. Kriterii diagnoza reaktivnykh artritov (proekt). Nauchno-prakticheskaya Revmatologiya 2003; 3: 82–83. [in Russian]
9. Bardin T., Enel C., Cornelis F. et al. Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum 1992; 35: 190–194.
10. Lassila K., Laasonen L., Leirisalo-Repo M. Antibiotic treatment and long term prognosis of reactive arthritis. Ann Rheum Dis 2003, 62: 655.
11. Kovalev Jyu.N., Il'in N.I. Bolezn' Rejtera. Chelyabinsk, Variant-kniga, 1993; 240. [in Russian]
12. Yli-Kerttula T., Luukkainen R., Yli-Kerttula U. et al. Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis. Ann Rheum Dis 2003; 62: 880–884.
13. Luccino B., Spinelli F.R., Perricone C. et al. Reactive arthritis: current treatment challenges and future perspectives. Clin Exp Rheumatol 2019; 37; 1065–1076.
14. Carter J.D., Espinosa L.R., Inman R.D. et al Combination antibiotics as a treatment for chronic Chlamydia-induced reactive arthritis: a doubleblind, placebo-controlled, prospective trial. Arthritis Rheum 2010; 62 (5): 1298–1307. doi: 10.1002/art.27394
15. Zeidler H., Hudson A.P. Chlamydia-Induced Reactive Arthritis: Disappearing Entity or Lack of Research? Current Rheumatology Reports 2019; 21: 63. https://doi.org/10.1007/s11926-019-0863-4.
16. Zeng H., Luo B., Zhang Yu. et al. Treatment of reactive arthritis with biological agents: a review. Bioscience Reports 2020; 40 BSR20191927. https://doi.org/10.1042/BSR20191927.
17. Wendling D., Prati C., Chouk M., Verhoeven F. Reactive arthritis: treatment challenges and future perspectives. Curr Rheumatol Rep 2020; 22 (7): 29. doi:10.1007/s11926-020-00904-9.
Review
For citations:
Belov B.S., Balabanova R.M. Reactive Arthritis: Modern Aspects of Diagnosis and Treatment. Antibiot Khimioter = Antibiotics and Chemotherapy. 2020;65(7-8):63-70. (In Russ.) https://doi.org/10.37489/0235-2990-2020-65-7-8-63-70